Leave it to Jami Rubin to put the Big Pharma CEO on the spot.
On Friday’s call with the top team at AbbVie, the salty Goldman Sachs analyst asked AbbVie CEO Rick Gonzalez point blank about an earlier comment that he had made about his willingness to do a $20 billion to $30 billion M&A deal.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,